(VIANEWS) – Shares of West Pharmaceutical (NYSE: WST) rose by a staggering 15.66% to $322.89 at 10:17 EST on Thursday, after five successive sessions in a row of gains. NYSE is sliding 1.01% to $15,854.48, after two sequential sessions in a row of losses. This seems, up until now, an all-around bearish trend trading session today.
West Pharmaceutical’s last close was $279.18, 34.16% below its 52-week high of $424.00.
About West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Earnings Per Share
As for profitability, West Pharmaceutical has a trailing twelve months EPS of $5.57.
PE Ratio
West Pharmaceutical has a trailing twelve months price to earnings ratio of 57.99. Meaning, the purchaser of the share is investing $57.99 for every dollar of annual earnings.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 1% and a drop 6.1% for the next.
Moving Average
West Pharmaceutical’s value is way above its 50-day moving average of $237.66 and way higher than its 200-day moving average of $284.87.
More news about West Pharmaceutical (WST).
